Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Alexander Batten, Maheshi Ramasamy et al.|The Lancet|2020

Cited by 2.6k